UPAC & iskup supports January, National Bible Month
last week of January, National Bible Week
January 23, National Bible Sunday
5 months to EMMANUEL
PACQUIAO 22

iskup is looking for electrical and mechanical trainees, legal age, high school drop out, 0943814499, 09916444376
in the news…
iskup supports January, National Bible Month; last week of January, National Bible Week; January 23,2022, National Bible Sunday
The National Telecommunications Commission warned watching public to withold any information to anyone offering job, it is scam.
Duque’s absences in House hearing, explained
By J.Lo
“I was not able to attend the hearings because of conflict with my earlier equally important official engagements,” Health Secretary Francisco Duque III explained why he was unable to attend hearings of House of Representatives panel that probed government’s COVID-19 response efforts last year.
The House Committee on Good Government and Public Accountability earlier issued committee report recommending charges against Duque and two others but recalled it later in the day.
Aside from Duque, those recommended to be charges were
former Food and Drug Administration (FDA) director general Eric Domingo and FDA Center for Drug Regulation and Research Director Joyce Cirunay.
The inquiry focused on the policies and guidelines of the Department of Health (DOH) and FDA for “registration, utilization, manufacture, distribution or sale of drug products for coronavirus disease.”
The committee report noted DOH and FDA’s supposed contradictory issuances and guidelines as well as reliance on just few members of medical professional associations.
These issuances appear “arbitrary and unreasonable” in light of circumstances the country was facing due to COVID-19 pandemic, according to the committee.
Duque, who welcomed recall of the committee report, said the DOH secretary has nothing to do with the day-to-day operations of FDA.
“As Chair of DOH Execom we guide them on certain policy issues and act on appeals brought before us by complainants adversely affected by FDA’s decisions,” he said.
“Unless the appeal is meritorious we almost always sustain FDA’s decisions,” Duque added.
Duque also said FDA has its own head “who are more knowledgeable and competent about the day to day regulatory operations of FDA.”
“FDA is dutybound to implement regulatory laws ensuring safety quality efficacy and cost-effectiveness of drugs medicines biologicals vaccines and devices since they are for public use,” he said.
Reacting to the committee report, Domingo earlier said
evaluation and approval of COVID-19 drug products were being done in proper and timely manner.
“All applications for COVID drugs were evaluated properly and approved in a timely manner based on scientific evidence of quality, safety and efficacy,” Duque concluded.
